Thursday, December 27, 2018 5:06:00 PM
I'm thinking in terms of Market Cap though. I'm also keeping in mind the handful of other medical cannabis / biotechs that have shot up like crazy on certain catalysts.
When OWCP, CNBX, and AXIM went ape-sheet -- they ran to $430M - $600M+ market caps.
The lower O/S and Float here certainly means it's just as possible. But, hopefully on legit news that keeps the share price up that high for a while.
CSE listing could cause a nice spark, but we need some good drug advancement news, IMO. With that talk with the FDA dating back to last year -- I'm really hoping NXEN receives approval to begin clinical trials and maybe receiving Orphan Drug Designation at the same time. That's the kind of thing that can cause those 1,000% gains over the course of days or weeks.
$0.2195 to $2.00 is 811% gain. There are a handful of OTC stocks weekly that see 250% - 1,000% gains in a single day -- sometimes because of splits and non-hype reasons but if you look at the volume you can usually differentiate. Today it was $NXUR, $GRPH, $SPRL, and $ADMG to name a few.
https://www.finscreener.com/screener/top-gainers/stocks/otc
Recent NXEN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 11:19:50 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 11:04:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:02:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/02/2023 08:02:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 10:06:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2023 09:41:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2023 07:35:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM